JL

John Langridge

CT Cv Therapeutics: 6 patents #20 of 71Top 30%
S( Syntex (U.S.A.): 4 patents #141 of 599Top 25%
SD Sterling Drug: 2 patents #68 of 246Top 30%
CB Campina Nederland Holding B.V.: 1 patents #3 of 11Top 30%
📍 Alnwick, GB: #1 of 15 inventorsTop 7%
Overall (All Time): #516,212 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
8865778 Extended release excipient and its use Linqiu Cao, Alexander Wilhelmus van Gessel 2014-10-21
6620814 Sustained release ranolazine formulations Andrew Wolff, Fiona Baker 2003-09-16
6617328 Sustained release ranolazine formulations Andrew Wolff, Fiona Baker 2003-09-09
6525057 Sustained release ranolazine formulations Andrew Wolff, Fiona Baker 2003-02-25
6503911 Sustained release ranolazine formulations Andrew Wolff, Fiona Baker 2003-01-07
6369062 Sustained release ranolazine formulations Andrew Wolff, Fiona Baker 2002-04-09
6303607 Method for administering a sustained release ranolanolazine formulation Andrew Wolff, Fiona Baker 2001-10-16
5209933 Long acting calcium channel blocker composition Calum B. MacFarlane, Alastair B. Selkirk, Michael J. Dey 1993-05-11
4806361 Medicaments in sustained release unit dose form Paul Jonathan Harrison, Christopher John Potter 1989-02-21
4717569 Unit dosage form of sparingly soluble medicaments Paul Jonathan Harrison, Christopher John Potter 1988-01-05